Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models.

However, there was no significant correlation between cMet expression with other clinicopathological parameters such as age, gender, tumor location, tumor size, tumor differentiation, or carcinoembryonic antigen (CEA), although there was an increasing trend in cMet expression with advancing TNM stage (Figure 1 B).To assess the predictive role of cMet for prognosis, Kaplan-Meier curves with a log-rank test for OS were performed.

also in 63,971 other papers